An MRI instead of a surgical procedure helped speed up the wait between diagnosis and treatment, UK research has found ...

Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat.com reports.

BladderPath trial found that patients with suspected invasive bladder cancer undergoing initial mpMRI were treated faster ...

Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) saw a large growth in short interest in December. As of December 31st, there was short interest totalling 5,500,000 shares, a growth of 8.7 ...

Biotech giant Gilead Sciences, Inc. GILD has put up a strong performance amid a volatile market. Shares of this biotech giant ...

Daiichi Sankyo buys solid tumour ADC from Glycotope for $132.5m Daiichi Sankyo has finalised the acquisition of intellectual ...

Executing in oncology with investigational BNT327/PM8002 combinations and mRNA cancer immunotherapy candidates as pan-tumor treatment approaches ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery ...

Patients with a common aggressive type of bladder cancer could get correct treatment significantly quicker as new research ...